Hospital-based addiction consult services show promise in improving opioid use disorder treatment uptake

FHS
July 30, 2024
3:16 am

Previous research has found that over 80 percent of people with opioid use disorder (OUD) do not receive evidence-based lifesaving medications.

Akero Therapeutics Marching On & Delivering Promising Results • Prudent Biotech

Akero Therapeutics is making strong progress in developing a treatment for NASH, an area of high unmet medical need. The company’s lead product candidate has

June 13, 2023

Hypertension drug may reduce heart failure risk in people recovering from heart attack

New research found that the medication spironolactone, often prescribed for hypertension (high blood pressure), may reduce the risk of heart failure in people recovering from

November 18, 2024

Modest updates to current school meal nutrition standards could lead to significant health benefits

Today’s school meals are much healthier than they were for the parents of American kids, but still 1 in 4 school meals are of poor

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.